Stocks To Sell Today, Feb 10: Aurobindo Pharma, Zydus Lifesciences and Navin Fluorine

• Maintain SELL
• Target Price: Rs1,010
• 3Q EBITDA beat led by currency tailwinds and strong Europe performance
• US business subdued; gross margin pressured by R&D spend
• Key watch: US recovery, biosimilar filings and Eugia ramp-up
• Risk-reward still unattractive; maintain Sell

Citi on Zydus Lifesciences

• Maintain SELL
• Target Price: Rs 900
• 3Q EBITDA beat aided by currency, India growth and acquisitions
• Base business margins under pressure due to higher R&D spend
• US and Medtech performance strong; sustainability to be monitored
• Valuation caps upside; maintain Sell

Citi on Navin Fluorine

• Maintain SELL
• Target Price: Rs5,550
• 3Q EBITDA up ~110% YoY; strong specialty chemicals and CDMO ramp-up
• Margin expansion driven by operating leverage and new projects
• Valuations rich at ~57x FY27E EV/EBITDA
• Upside largely priced in; maintain Sell

Morgan Stanley on Bajaj Electricals

• Maintain Underweight
• Target Price: Rs432
• Revenue declined 19% YoY; ~20% below estimates due to sharp consumer segment weakness
• Consumer products revenue -25% YoY; EBIT margin at -4.6% due to operating deleverage
• Lighting segment relatively resilient; revenue +9% YoY with margin expansion
• Adjusted PAT at loss vs expectations of profit; meaningful earnings downgrade
• Channel inventory correction underway; price hikes of 2-5% taken to offset cost inflation
• Near-term recovery visibility remains weak; downside risks persist

Citi on Lenskart Solutions - Initiation

• Initiate NEUTRAL
• Target Price: Rs500
• Strong growth visibility driven by vertical integration and scale
• High execution quality but valuations largely factor in positives
• Key risks: supply chain, competition, store economics
• Neutral due to balanced risk-reward

Morgan Stanley on Crompton Greaves Consumer

• Maintain Equal-weight
• Target Price: Rs310
• 3Q adj. PAT beat MSe by 22% led by EBITDA beat and lower tax
• ECD revenues grew 8% YoY; margins compressed on product mix
• Lighting delivered margin-led outperformance; Butterfly margins improved
• Entry into residential wires expands addressable market; rollout to be phased
• Fans pricing actions and solar pumps execution supportive near term

(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money related decisions.)